Drug Information

Drug General Information
Drug ID
D02PKO
Former ID
DNC004460
Drug Name
3-(4-Methoxy-benzenesulfonyl)-cyclopentanethiol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [525535]
Formula
C12H16O3S2
Canonical SMILES
COC1=CC=C(C=C1)S(=O)(=O)C2CCC(C2)S
InChI
1S/C12H16O3S2/c1-15-9-2-5-11(6-3-9)17(13,14)12-7-4-10(16)8-12/h2-3,5-6,10,12,16H,4,7-8H2,1H3
InChIKey
JDPMCWHMTGTQGU-UHFFFAOYSA-N
PubChem Compound ID
44294636
Target and Pathway
Target(s) Collagenase 3 Target Info Inhibitor [525535]
NetPath Pathway IL1 Signaling Pathway
PANTHER Pathway Alzheimer disease-presenilin pathway
Plasminogen activating cascade
Pathway Interaction Database Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
Reactome Collagen degradation
Degradation of the extracellular matrix
Activation of Matrix Metalloproteinases
Assembly of collagen fibrils and other multimeric structures
WikiPathways Endochondral Ossification
Activation of Matrix Metalloproteinases
Oncostatin M Signaling Pathway
AGE/RAGE pathway
Matrix Metalloproteinases
References
Ref 525535Bioorg Med Chem Lett. 1999 Jul 5;9(13):1757-60.Synthesis and identification of conformationally constrained selective MMP inhibitors.
Ref 525535Bioorg Med Chem Lett. 1999 Jul 5;9(13):1757-60.Synthesis and identification of conformationally constrained selective MMP inhibitors.